Dr. Matthew B. Donovan, MD
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- University of Miami, Lm Miller School of Medicine (2016)
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 1,265
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Medical school: University of Miami, Lm Miller School of Medicine
- 2016Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
FL license ME145329 -
Retina Specialist (Ophthalmology) Physician
FL license ME145329
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Retina Vitreous Consultants (45 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,265
- Services billed
- 37,080
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 11,640 | 57 |
| Imaging of retina | 1,658 | 935 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,489 | 976 |
| Photography of the retina | 690 | 607 |
| Injection of drug into eye | 497 | 130 |
| Injection, aflibercept, 1 mg | 417 | 74 |
| Injection, pegcetacoplan, intravitreal, 1 mg | 345 | 15 |
| Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 166 | 17 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 149 | 144 |
| Established patient office or other outpatient visit, 20-29 minutes | 144 | 122 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Clearwater, FL | 117 |
| Ketorolac Tromethamine Other prescribers in Clearwater, FL | 113 |
| Latanoprost Other prescribers in Clearwater, FL | 63 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Clearwater, FL | 56 |
| Brimonidine Tartrate Other prescribers in Clearwater, FL | 36 |
| Timolol Maleate Other prescribers in Clearwater, FL | 24 |
| Lumigan (bimatoprost) Other prescribers in Clearwater, FL | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 17 payments worth $2,751 in total to this clinician.
| Apellis Pharmaceuticals, Inc. | $2,505 |
|---|---|
| Astellas Pharma US Inc | $127 |
| Genentech USA, Inc. | $52.10 |
| Regeneron Healthcare Solutions, Inc. | $40.68 |
| Harrow Eye, LLC | $26.88 |
| Consulting Fee | $2,164 |
|---|---|
| Food and Beverage | $588 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Apellis Pharmaceuticals, Inc. Oct 18, 2025 | Consulting Fee Syfovre · Ophthalmology | $1,443 |
| Apellis Pharmaceuticals, Inc. May 21, 2025 | Consulting Fee Syfovre · Ophthalmology | $577 |
| Apellis Pharmaceuticals, Inc. Dec 10, 2025 | Consulting Fee Syfovre · Ophthalmology | $144 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.